Clinical Trial Update: Patient With MMRR Treated With Belantamab Mafotidine on Monotherapy

View source ↗

Summary

A completed clinical trial update describes a patient with multiple myeloma treated with belantamab mafotidine as monotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Belantamab Mafotidine (belantamab mafodotin)

Snippet

Sponsor: Fondazione EMN Italy Onlus | Conditions: Multiple Myeloma | Status: COMPLETED